Mostrar el registro sencillo

dc.contributor.authorFernández-Cladera Y.
dc.contributor.authorGarcía-González M.
dc.contributor.authorHernández-Díaz M.
dc.contributor.authorGómez-Bernal F.
dc.contributor.authorQuevedo-Abeledo J.C.
dc.contributor.authorGonzález-Rivero, Agustín F.
dc.contributor.authorVera-González, Antonia de
dc.contributor.authorGómez-Moreno, Cristina
dc.contributor.authorGonzález-Gay Mantecón, Miguel Ángel 
dc.contributor.authorFerraz-Amaro, Iván
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2024-10-09T17:26:39Z
dc.date.available2024-10-09T17:26:39Z
dc.date.issued2024-04-27
dc.identifier.issn2227-9059
dc.identifier.urihttps://hdl.handle.net/10902/34196
dc.description.abstractSystemic lupus erythematosus (SLE) is a chronic autoimmune disorder identified by hematological abnormalities including anemia, leukopenia, and thrombocytopenia. Complement system disturbance is implicated in the pathogenesis of SLE. In this work, we aim to study how a full assessment of the complement system, which includes the evaluation of its three pathways, relates to blood cell counts in a population of patients with SLE. New-generation functional assays of the classical, alternative, and lectin pathways of the complement system were conducted in 284 patients with SLE. Additionally, serum levels of inactive molecules (C1q, C2, C3, C4, factor D) and activated molecules (C3a), as well as regulators (C1-inhibitor and factor H), were evaluated. Complete blood cell counts were analyzed. Multivariable linear regression analysis was performed to study the relationship of hematological profiles with this full characterization of the complement system. After multivariable adjustments that included age, sex, SLICC-DI (damage), and SLEDAI (activity) scores, as well as the use of aspirin, prednisone, methotrexate, azathioprine, and mycophenolate mofetil, several relationships were observed between the C pathways and the individual products and blood cells profile. Lower values of C1q and C2 were associated with lower hemoglobin levels. Lower leukocyte counts showed significantly lower values of C4, C1 inhibitor, C3, factor D, and alternative pathway functional levels. Neutrophil counts showed significant negative relationships only with the alternative pathway and C1-inh. In the case of lymphocytes, associations were found, especially with functional tests of the classical and alternative pathways, as well as with C2, C4, C3, and C3a. On the contrary, for platelets, significance was only observed, after multivariable adjustment, with lower C2 concentrations. In conclusion, the serum complement system and hematological profile in SLE are independently linked, after adjustment for disease activity and damage. These relationships are basically negative and are predominantly found in lymphocytes.es_ES
dc.description.sponsorshipFunding: This study was funded by a grant to I.F.-A. by Instituto de Salud Carlos III (ISCIII) through the project PI20/00084 and co-funded by the European Uniones_ES
dc.format.extent11 p.es_ES
dc.language.isoenges_ES
dc.publisherMDPI AGes_ES
dc.rights© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceBiomedicines, 2024, 27, 12(5), 967es_ES
dc.subject.otherComplement systemes_ES
dc.subject.otherSystemic lupus erythematosuses_ES
dc.subject.otherBlood cells countes_ES
dc.subject.otherHemoglobines_ES
dc.subject.otherLeucocyteses_ES
dc.subject.otherNeutrophilses_ES
dc.subject.otherMonocyteses_ES
dc.subject.otherLymphocyteses_ES
dc.subject.otherPlateletses_ES
dc.titleRelationship of hematological profiles with the serum complement system in patients with systemic Lupus erythematosuses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.3390/biomedicines12050967es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.3390/biomedicines12050967
dc.type.versionacceptedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).Excepto si se señala otra cosa, la licencia del ítem se describe como © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).